intravenous glutathione pharmacokinetics halflife human Full article: Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting CXCR4 Drug Half Life - an

67 Although people with significant psychiatric illness are typically excluded from clinical trials, no increase in psychiatric disorders has been observed in these studies

R., Chudasama, V.* Chem Sci , 2024, 15, 8557-8568 Abstract Protein modification has garnered increasing interest over the past few decades and has become an important tool in many aspects of chemical biology

Patients with osteoporosis often require high-dose vitamin D therapy to maintain optimal bone density, and intramuscular injections provide a reliable method of delivering these high doses

Lee JY, Jung GY, Heo HJ, Yun MR, Park JY, Bae SS et al